Also from this source

You just read:

Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma

News provided by

Keryx Biopharmaceuticals, Inc.

Dec 06, 2010, 08:30 EST